EBioMedicine Journal Citation Rate 2026
2352-3964
Elsevier BV
NL
Q1 Quartile Open Access Top Tier
About EBioMedicine
EBioMedicine (E) is a peer-reviewed academic journal covering COVID-19 Clinical Research Studies and Epigenetics and DNA Methylation, published by Elsevier BV in NL, catalogued under ISSN 2352-3964. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 8.28 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $3500 USD. OpenAlex records 6,371 works and 254,618 citations, with an h-index of 181.
EBioMedicine Citation Rate 2026 — In Context
EBioMedicine has a 2025 2-Year Citation Rate (OpenAlex) of 8.28, placing it in the Q1 quartile within the COVID-19 Clinical Research Studies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, EBioMedicine makes all articles freely available to readers for an Article Processing Charge of approximately $3500 USD.
Researchers looking to publish in EBioMedicine should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare EBioMedicine against similar journals in the field, use our journal comparison tool.
Submission Tips for EBioMedicine
- Budget $3500 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers COVID-19 Clinical Research Studies, Epigenetics and DNA Methylation, Gut microbiota and health. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How EBioMedicine Compares
Compared against 46 journals in the same research areas.
| ISSN (Print) | 2352-3964 |
|---|---|
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | $3500 USD |
| h-index | 184 |
| Total Works | 6,398 |
| Total Citations | 259,333 |
| 2-yr Mean Citedness | 10.11 (OpenAlex) |
| DOAJ | Listed |
In-depth profile & metrics
EBioMedicine is published by Elsevier BV and based in Netherlands. It publishes open access with an article-processing charge of USD 3500.
In our subject taxonomy, EBioMedicine is classified under COVID-19 Clinical Research Studies, Epigenetics and DNA Methylation, Gut microbiota and health and HIV Research and Treatment.
EBioMedicine is indexed in the DOAJ and OpenAlex. DOAJ listing confirms the journal's open-access policies have been independently vetted.
OpenAlex records 6,398 works that have together drawn 259,333 citations, giving the journal an h-index of 184; its most recent citation rate stands at 8.276; OpenAlex puts its two-year mean citedness at 10.11.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about EBioMedicine
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 8.276 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 548 | 4,097 |
| 2024 | 586 | 10,889 |
| 2023 | 508 | 18,006 |
| 2022 | 617 | 26,396 |
| 2021 | 614 | 25,585 |
| 2020 | 580 | 32,699 |
| 2019 | 727 | 40,709 |
| 2018 | 539 | 31,834 |
| 2017 | 402 | 22,493 |
| 2016 | 477 | 28,479 |
| 2015 | 375 | 16,274 |
| 2014 | 51 | 1,613 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where EBioMedicine most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Compare Journals
Compare EBioMedicine against similar publications in its field:
Related Journals in Your Field
-
Aging Cell Wiley IF 64.50
-
Cell Reports Elsevier IF 64.50
-
Cell Death and Disease Springer Nature IF 64.50
-
Cancer Cell Elsevier IF 64.50
-
DNA and Cell Biology Mary Ann Liebert IF 64.50
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S2531685872
Get weekly updates for COVID-19 Clinical Research Studies journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.